@techcrunch.com 2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@xconomy.com 3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@techcrunch.com 5 years ago
Public shareholders got high today on Tilray, the first marijuana company to IPO on Nasdaq